163 related articles for article (PubMed ID: 16807067)
1. Rho GDP dissociation inhibitors as potential targets for anticancer treatment.
Zhang B
Drug Resist Updat; 2006 Jun; 9(3):134-41. PubMed ID: 16807067
[TBL] [Abstract][Full Text] [Related]
2. RhoGDIs revisited: novel roles in Rho regulation.
Dransart E; Olofsson B; Cherfils J
Traffic; 2005 Nov; 6(11):957-66. PubMed ID: 16190977
[TBL] [Abstract][Full Text] [Related]
3. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
4. RhoGDI-3, a promising system to investigate the regulatory function of rhoGDIs: uncoupling of inhibitory and shuttling functions of rhoGDIs.
Dransart E; Morin A; Cherfils J; Olofsson B
Biochem Soc Trans; 2005 Aug; 33(Pt 4):623-6. PubMed ID: 16042558
[TBL] [Abstract][Full Text] [Related]
5. Rho GTPases: potential candidates for anticancer therapy.
Aznar S; Fernández-Valerón P; Espina C; Lacal JC
Cancer Lett; 2004 Apr; 206(2):181-91. PubMed ID: 15013523
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Rho GTPases by RhoGDIs in Human Cancers.
Cho HJ; Kim JT; Baek KE; Kim BY; Lee HG
Cells; 2019 Sep; 8(9):. PubMed ID: 31492019
[TBL] [Abstract][Full Text] [Related]
7. Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs.
Ota T; Maeda M; Okamoto M; Tatsuka M
BMC Syst Biol; 2015 Jan; 9():3. PubMed ID: 25628036
[TBL] [Abstract][Full Text] [Related]
8. RhoGDI signaling provides targets for cancer therapy.
Harding MA; Theodorescu D
Eur J Cancer; 2010 May; 46(7):1252-9. PubMed ID: 20347589
[TBL] [Abstract][Full Text] [Related]
9. Using inhibitors of prenylation to block localization and transforming activity.
Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
[TBL] [Abstract][Full Text] [Related]
10. A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.
Ahmad Mokhtar AMB; Ahmed SBM; Darling NJ; Harris M; Mott HR; Owen D
Biochemistry; 2021 May; 60(19):1533-1551. PubMed ID: 33913706
[TBL] [Abstract][Full Text] [Related]
11. RhoGDI2 as a therapeutic target in cancer.
Cho HJ; Baek KE; Yoo J
Expert Opin Ther Targets; 2010 Jan; 14(1):67-75. PubMed ID: 20001211
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of RhoGDI inhibitory activity on vacuole membrane fusion.
Logan MR; Jones L; Forsberg D; Bodman A; Baier A; Eitzen G
Biochem J; 2011 Mar; 434(3):445-57. PubMed ID: 21171963
[TBL] [Abstract][Full Text] [Related]
13. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.
Walker K; Olson MF
Curr Opin Genet Dev; 2005 Feb; 15(1):62-8. PubMed ID: 15661535
[TBL] [Abstract][Full Text] [Related]
14. GDIs: central regulatory molecules in Rho GTPase activation.
DerMardirossian C; Bokoch GM
Trends Cell Biol; 2005 Jul; 15(7):356-63. PubMed ID: 15921909
[TBL] [Abstract][Full Text] [Related]
15. Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases.
Aspenström P; Ruusala A; Pacholsky D
Exp Cell Res; 2007 Oct; 313(17):3673-9. PubMed ID: 17850788
[TBL] [Abstract][Full Text] [Related]
16. Expression of RHOGTPase regulators in human myometrium.
O'Brien M; Flynn D; Mullins B; Morrison JJ; Smith TJ
Reprod Biol Endocrinol; 2008 Jan; 6():1. PubMed ID: 18190708
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells.
Reimer J; Bien S; Sonnemann J; Beck JF; Wieland T; Kroemer HK; Ritter CA
Anticancer Drugs; 2007 Mar; 18(3):333-40. PubMed ID: 17264767
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling of inhibitory and shuttling functions of rho GDP dissociation inhibitors.
Dransart E; Morin A; Cherfils J; Olofsson B
J Biol Chem; 2005 Feb; 280(6):4674-83. PubMed ID: 15513926
[TBL] [Abstract][Full Text] [Related]
19. Rho-regulatory proteins in breast cancer cell motility and invasion.
Lin M; van Golen KL
Breast Cancer Res Treat; 2004 Mar; 84(1):49-60. PubMed ID: 14999154
[TBL] [Abstract][Full Text] [Related]
20. Rho GTPases in cancer cell biology.
Vega FM; Ridley AJ
FEBS Lett; 2008 Jun; 582(14):2093-101. PubMed ID: 18460342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
